DI-042 Management of liposomal anthracycline extravasations: Use of desrazoxane von Romero, A Caballero, Martínez, D Blánquez, Ramos, C Lara, Torne, G Rodriguez, Romero, R Morón, Hidalgo, I Casas, Medina, MC González, Corpas, M Valle, Delgado, A Rodríguez, Barrera, J Cabeza

Volltext

4CPS-005 GLP-1 agonist liraglutide as add-on therapy in type 2 diabetes von Blánquez Martínez, D, Hayon Ponce, M, Casas Hidalgo, I, Diaz Villamarin, X, Raquel, ÁS, Nieto Gómez, P, Davila Fajardo, C

Volltext

4CPS-011 Prevalence and relationship between hypovitaminosis D and insulin resistance in obese patient candidates for bariatric surgery von Blánquez Martínez, D, Hayon Ponce, M, Nieto Gómez, P, Raquel, ÁS, Diaz Villamarin, X, Garcia Fernandez, C, Davila Fajardo, C

Volltext

5PSQ-028 Cardiovascular risk factor in individuals with gender identity disorder or cross-sex hormone therapy von Martínez, D Blánquez, Ponce, M Hayon, Romero, A Caballero, Villamarin, X Diaz, Gómez, P Nieto, Raya, P Moreno, Delgado, A Rodriguez, Sanchez, R Alvarez, Fajardo, C Davila

Volltext

CP-084 Interleukin-6–174G>C genetic polymorphism (RS1800795) and the influence of clinical variables on the response to TOCILIZUMAB von Díaz-Villamarín, X, Dávila-Fajardo, CL, Blánquez-Martínez, D, Caballero-Romero, A, Rodríguez-Delgado, A, González-Medina, M

Volltext

CP-091 SLC9A7 G/T (RS7055107) genetic polymorphism on the response to tocilizumab in rheumatoid arthritis patients von González-Medina, M, Díaz-Villamarín, X, Dávila-Fajardo, CL, Moreno-raya, P, Blánquez-Martínez, D, Cabeza-Barrera, J

Volltext

CP-086 CD69 A>G (RS11052877) genetic polymorphism on the response to tocilizumab in rheumatoid arthritis patients von Díaz-Villamarín, X, Dávila-Fajardo, C, González-Medina, M, Blánquez-Martínez, D, Moreno-Raya, P, Cabeza-Barrera, J

Volltext

5PSQ-008 CYP2C19 SNP’s influence on clopidogrel response in peripheral artery disease patients von Díaz-Villamarín, X, Dávila-Fajardo, CL, Blánquez-Martínez, D, Fernández-Gómez, E, Antúnez-Rodríguez, A, Raquel, ÁS

Volltext

5PSQ-009 CYP2C19 SNP’s influence on clopidogrel response in cerebrovascular disease patients: final results von Díaz-Villamarín, X, Dávila-Fajardo, CL, Blánquez-Martínez, D, Fernández-Gómez, E, Antúnez-Rodríguez, A, Raquel, ÁS

Volltext

DI-009 Non-valvular atrial fibrillation: criteria for prescription of novel oral anticoagulants von Torne, G Rodriguez, Medina, M Gonzalez, Martinez, D Blanquez

Volltext

CP-009 Risk assessment of diabetes ketoacidosis in type 2 diabetes mellitus patients treated with sodium–glucose cotransporter type 2 inhibitors von Martinez, D Blanquez, Ponce, M Hayon, Romero, A Caballero, Villamarin, X Diaz, Medina, MDC Gonzalez, Hidalgo, I Casas, Delgado, A Rodriguez, Raya, P Moreno

Volltext

CP-123 Non-valvular atrial fibrillation: Effectiveness of vitamin K antagonist vs novel oral anticoagulant treatments von Torne, G Rodriguez, Garre, M Cañadas, Romero, A Caballero, Martinez, D Blanquez, Hidalgo, I Casas, Barrera, J Cabeza

Volltext

DI-055 Evaluation of tocilizumab response in rheumatoid arthritis. Comparision of the results with the clinical trial von Medina, MDC Gonzalez, Fajardo, C Davila, Villamarin, X Diaz, Pino, MJ Soto, Martinez, LJ, Martinez, D Blanquez, Corpas, M Valle, Alvarez, E Raya, Romero, R Moron, Barrera, J Cabeza

Volltext